OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells.
- DOI
- 10.1182/blood-2014-06-583518
- Published
- 2015 Jan 8
- Container
- Blood
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1182/blood-2014-06-583518,
title = {OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells.},
author = {Liu TM and Ling Y and Woyach JA and Beckwith K and Yeh YY and Hertlein E and Zhang X and Lehman A and Awan F and Jones JA and Andritsos LA and Maddocks K and MacMurray J and Salunke SB and Chen CS and Phelps MA and Byrd JC and Johnson AJ},
year = {2015},
journal = {Blood},
doi = {10.1182/blood-2014-06-583518},
url = {https://doi.org/10.1182/blood-2014-06-583518}
}RIS
TY - JOUR TI - OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells. AU - Liu TM AU - Ling Y AU - Woyach JA AU - Beckwith K AU - Yeh YY AU - Hertlein E AU - Zhang X AU - Lehman A AU - Awan F AU - Jones JA AU - Andritsos LA AU - Maddocks K AU - MacMurray J AU - Salunke SB AU - Chen CS AU - Phelps MA AU - Byrd JC AU - Johnson AJ PY - 2015 JO - Blood DO - 10.1182/blood-2014-06-583518 UR - https://doi.org/10.1182/blood-2014-06-583518 ER -
APA
TM, L., Y, L., JA, W., K, B., YY, Y., E, H., X, Z., A, L., F, A., JA, J., LA, A., K, M., J, M., SB, S., CS, C., MA, P., JC, B., & AJ, J. (2015). OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells.. Blood. https://doi.org/10.1182/blood-2014-06-583518
Source records
- pubmed · retrieved 2026-09-27T00:46:51.730Z